Covalon Technologies Ltd
XTSX:COV

Watchlist Manager
Covalon Technologies Ltd Logo
Covalon Technologies Ltd
XTSX:COV
Watchlist
Price: 2.71 CAD -2.52% Market Closed
Market Cap: 74.3m CAD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

COV Price Targets Summary
Covalon Technologies Ltd

Wall Street analysts forecast COV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for COV is 4.49 CAD with a low forecast of 4.44 CAD and a high forecast of 4.62 CAD.

COV Lowest Forecast
Wall Street Target
4.44 CAD
64% Upside
COV Average Forecast
Wall Street Target
4.49 CAD
66% Upside
COV Highest Forecast
Wall Street Target
4.62 CAD
70% Upside
Lowest
Price Target
4.44 CAD
64% Upside
Average
Price Target
4.49 CAD
66% Upside
Highest
Price Target
4.62 CAD
70% Upside
Covalon Technologies Ltd Competitors:
Price Targets
SLNO
Soleno Therapeutics Inc
46% Upside
RNA
Avidity Biosciences Inc
121% Upside
002007
Hualan Biological Engineering Inc
23% Upside
G
GNFT
Genfit SA
153% Upside
SLNO
Soleno Therapeutics Inc
46% Upside
RNA
Avidity Biosciences Inc
121% Upside
002007
Hualan Biological Engineering Inc
23% Upside
G
GNFT
Genfit SA
153% Upside
688235
Beigene Ltd
14% Upside
DVAX
Dynavax Technologies Corp
149% Upside
300122
Chongqing Zhifei Biological Products Co Ltd
56% Upside
KMDA
Kamada Ltd
123% Upside

Revenue
Forecast

Revenue Estimate
Covalon Technologies Ltd

For the last 8 years the compound annual growth rate for Covalon Technologies Ltd's revenue is 21%. The projected CAGR for the next 3 years is 13%.

21%
Past Growth
13%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Covalon Technologies Ltd

The compound annual growth rate of Covalon Technologies Ltd's operating income for the next 3 years is 41%.

N/A
Past Growth
41%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Covalon Technologies Ltd

The compound annual growth rate of Covalon Technologies Ltd's net income for the next 3 years is 17%.

N/A
Past Growth
17%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
COV intrinsic value, competitors valuation, and company profile.
DCF Valuation
COV stock valuation using Discount Cash Flow valuation method.
Relative Valuation
COV stock valuation using valuation multiples.
Wall Street Estimates
COV price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
COV stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is COV's stock price target?
Price Target
4.49 CAD

According to Wall Street analysts, the average 1-year price target for COV is 4.49 CAD with a low forecast of 4.44 CAD and a high forecast of 4.62 CAD.

What is Covalon Technologies Ltd's Revenue forecast?
Projected CAGR
13%

For the last 8 years the compound annual growth rate for Covalon Technologies Ltd's revenue is 21%. The projected CAGR for the next 3 years is 13%.

What is Covalon Technologies Ltd's Operating Income forecast?
Projected CAGR
41%

The compound annual growth rate of Covalon Technologies Ltd's operating income for the next 3 years is 41%.

What is Covalon Technologies Ltd's Net Income forecast?
Projected CAGR
17%

The compound annual growth rate of Covalon Technologies Ltd's net income for the next 3 years is 17%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 256,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.